# Seal Rock Therapeutics, Inc. — Form D

Seal Rock Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-24. The offering totals $6.0M, of which $2.5M was reported sold. Industry: Other.

## Offering

- Filed: 2022-02-24
- Form: D
- Accession: 0001911787-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $2.5M
- Remaining: $3.5M
- Investors: 16
- Date of first sale: 2022-01-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-434869

## Issuer

- Name: Seal Rock Therapeutics, Inc.
- CIK: 0001911787
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: WEWORK C/O SEAL ROCK THERAPEUTICS, SEATTLE, WA, 98109
- Phone: 2062402143

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Neil McDonnell | Director | Burnaby, A1 |
| Artur Plonowski | Director | Seattle, WA |
| Keith Wycoff | Director | Seattle, WA |
| Neil McDonnell | Executive Officer | Burnaby, A1 |
| Artur Plonowski | Executive Officer | Seattle, WA |
| Neil McDonnell | Promoter | Burnaby, A1 |
| Artur Plonowski | Promoter | Seattle, WA |

## More

- [CIK 1911787 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1911787&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001911787-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.